lymphoma
Showing NaN - NaN of 239
Lymphoma Trial in Houston (PCV20)
Not yet recruiting
- Lymphoma
- PCV20
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2023
Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)
Completed
- Solid Tumor
- Lymphoma
- MK-2118 (IT)
- +2 more
-
La Jolla, California
- +7 more
Jan 23, 2023
Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
-
Los Angeles, California
- +4 more
Jan 18, 2023
Lymphoma Trial in Houston (cell-free DNA)
Not yet recruiting
- Lymphoma
- cell-free DNA
-
Houston, TexasMD Anderson Cancer Center
Dec 22, 2022
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Leukemia, Lymphoma Trial in Houston (Ofatumumab)
Active, not recruiting
- Leukemia
- Lymphoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 9, 2022
Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)
Recruiting
- Lymphoma
- Radiation Therapy
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 9, 2022
CB-Long-Term Safety Study (CB-LTSS)
Enrolling by invitation
- Lymphoma, Non-Hodgkin
- +7 more
- Allogeneic CAR-T therapy
-
Irvine, California
- +3 more
Nov 18, 2022
Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)
Active, not recruiting
- Leukemia
- Lymphoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Lymphoma Trial in Houston (Ibritumomab Tiuxetan (Zevalin), Rituximab)
Completed
- Lymphoma
- Ibritumomab Tiuxetan (Zevalin)
- Rituximab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 30, 2022
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)
Completed
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
-
Tucson, Arizona
- +422 more
Aug 16, 2022
Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- +3 more
- Oral repotrectinib (TPX-0005)
-
Los Angeles, California
- +27 more
Aug 9, 2022
Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)
Not yet recruiting
- Lymphoma
- Mantle Cell Lymphoma
- Acalabrutinib
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022